Home › Companies › Biotechnology, Consulting, Manufacturing, Therapeutics › Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.
Based based in Europe, Middle East, and Africa (EMEA), Ascend Gene & Cell Therapies works in biotechnology, consulting, manufacturing, therapeutics, founded in 2021.
Within the biotechnology, consulting, manufacturing, therapeutics space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Europe, Middle East, and Africa (EMEA).
It is recorded at the Series_A stage.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $132.5M.
| Sector | Biotechnology, Consulting, Manufacturing, Therapeutics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2021 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $132,524,999 |
Website: www.ascend-gctx.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account